Pharmaceutical care for elderly patients in a large hospital

Authors

  • Cinthia Mayumi Tanaka Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Endereço: Av. Dr. Enéas Carvalho de Aguiar, 255 - Cerqueira César, CEP: 05403-900, São Paulo.
  • Stéphanie de Souza Costa Viana Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Endereço: Av. Dr. Enéas Carvalho de Aguiar, 255 - Cerqueira César, São Paulo
  • Priscilla Alves Rocha Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Endereço: Av. Dr. Enéas Carvalho de Aguiar, 255 - Cerqueira César, São Paulo

DOI:

https://doi.org/10.14450/2318-9312.v34.e3.a2022.pp248-259

Keywords:

elderly health, multimorbidity, polypharmacy, pharmaceutical services

Abstract

The aging process is often associated with the presence of multiple comorbidities and, consequently, with the presence of polypharmacy. Furthermore, older individuals usually have conditions that demand particular
attention in health care, such as the presence of cognitive impairment, physiological changes, and the need for social support, which can compromise the autonomy of these individuals. The present study aimed to describe the clinical and sociodemographic profi le of older patients followed up in a large hospital located in the city of São Paulo, SP, Brazil, the clinical-assistance activities developed in pharmaceutical care and points to be improved. This is a cross-sectional study, with data collection in computerized institutional
systems, retrospectively, from June 2018 to July 2021. Sociodemographic and  care variables related to pharmacotherapeutic follow-up were considered, where the mean age of the study population was 79 ±7 years old, with low schooling and female prevalence. An average of 5 ±2.5 comorbidities were observed per patient, using approximately 13 ± 3.4 medications and a mean pharmacotherapeutic follow-up time of 12 ±10.8 months, with a predominance of 10 months. The main points of pharmaceutical intervention were related to adherence to treatment, poor awareness about pharmacotherapy, prescriptions duplicity, and inadequate storage of medicines, among others, for which strategies were developed to solve these problems, with an emphasis on health education actions, development of medication chart and request
for home glucose and blood pressure self-monitoring. In addition, the limitations found due to the lack of records of interventions with the medical team and information on loss to follow-up indicate the opportunity to improve pharmaceutical records.

Downloads

Published

2022-09-30

How to Cite

Tanaka, C. M., de Souza Costa Viana, S., & Alves Rocha, P. (2022). Pharmaceutical care for elderly patients in a large hospital. Infarma - Pharmaceutical Sciences, 34(3), 248–259. https://doi.org/10.14450/2318-9312.v34.e3.a2022.pp248-259

Issue

Vol. 34 No. 3 (2022)

Section

Original article

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).